Barclays lowered the firm’s price target on Revance (RVNC) to $3 from $7 and keeps an Equal Weight rating on the shares.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVNC:
- Unusually active option classes on open December 12th
- Revance receives acquisition offer from Crown Laboratories for $3.10 per share
- Unusually active option classes on open December 10th
- Revance price target lowered to $3.10 from $6.66 at Mizuho
- Omnicom to acquire Interpublic, China to investigate Nvidia: Morning Buzz